Parkinson

How Jens Schwamborn contributes to corona research with 3D mini-brains. Jens Schwamborn Jens Schwamborn is currently studying the effects of the virus on the brain with his research team at OrganoTherpeutics using 3D mini brain models. These were originally developed to study Parkinson’s disease, but are also proving useful in the current pandemic situation. – […]

About Prof. Jens Schwamborn and his project on treatment of Parkinson’s disease Jens Schwamborn Together with his partner Javier Jarazo, neuroscientist Prof. Jens Schwamborn has been researching the production of 3D brain organoids, also known as mini-brains, for years. The two founders of the research company OrganoTherapeutics specialize in organoids for the midbrain, which are

Jens Schwamborn s brain organoids help in drug discovery for corona drugs Jens Schwamborn Neurobiologist Prof. Jens Schwamborn develops mini-brains. What initially sounds like a science fiction movie has long been reality in the research labs of OrganoTherapeutics, the company Jens Schwamborn founded with his colleague Javier Jarazo as an offshoot of the University of

Jens Schwamborn develops mini-brains that can be used to test drugs Jens Schwamborn Prof. Jens Schwamborn is a neuroscientist. His Luxembourg-based company OrganoTherapeutics, an offshoot of the University of Luxembourg, is dedicated to development and research using brain organoids. These are mini-brains grown in vitro that can be used to research diseases and test active

Neuroscientist Jens Schwamborn grows brain organoids. Jens Schwamborn Until now, Parkinson’s disease has been considered incurable – which inspired Prof. Jens Schwamborn, together with his colleague Javier Jarazo, to found OrganoTherapeutics, a spin-off company of the University of Luxembourg / Luxembourg Centre for Systems Biomedicine (LCSB) in 2019, in order to be able to dedicate